By Izzy Wood (Drug Target Review)2023-05-08T12:00:13
US researchers developed a next-generation computational tool called NetBID2 that can uncover difficult-to-identify proteins that drive biological processes contributing to cancer.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-07-03T10:28:23
Sponsored by Merck
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2023-06-20T12:34:32
Sponsored by NanoTemper Technologies
2023-03-03T14:06:14
Sponsored by Bio-Techne
Site powered by Webvision Cloud